LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 330,981 Value ($000) $1 Avg Close $1.73 Range $1.53 - $2.09
Q3 2025
Shares 670,856 Value ($000) $1 Avg Close $1.18 Range $0.85 - $1.80
Q2 2025
Shares 897,611 Value ($000) $1 Avg Close $0.59 Range $0.37 - $1.15
Q1 2025
Shares 936,892 Value ($000) $0 Avg Close $0.59 Range $0.45 - $0.75
Q4 2024
Shares 408,837 Value ($000) $0 Avg Close $0.73 Range $0.48 - $0.97
Q3 2024
Shares 93,032 Value ($000) $0 Avg Close $0.93 Range $0.77 - $1.15
Q2 2023
Shares 13,196 Value ($000) $0 Avg Close $1.38 Range $1.24 - $1.57
Q3 2022
Shares 48,628 Value ($000) $55 Avg Close $1.47 Range $1.11 - $1.79
Q2 2022
Shares 118,308 Value ($000) $187 Avg Close $1.32 Range $1.10 - $1.64
Q1 2022
Shares 72,506 Value ($000) $112 Avg Close $1.55 Range $1.18 - $2.58
Q1 2021
Shares 80,000 Value ($000) $188 Avg Close $2.40 Range $1.55 - $3.13
Q2 2020
Shares 15,191 Value ($000) $13 Avg Close $0.88 Range $0.70 - $1.20